Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):e39–e44. doi: 10.1097/SPV.0000000000000790

Figure 2. Postmenopausal women with a history of recurrent UTI not on vaginal estrogen therapy display increased inflammatory cell influx in the urine.

Figure 2.

Representative samples from each group. (A) At baseline, patients with rUTI demonstrate significantly higher urine inflammation scores compared to patients without rUTI (0.93 vs 0.12). (B) Follow-up evaluation demonstrated significant decrease in urine inflammation scores after 3 months of VET in patients with rUTI (0.93 vs 0.38). rUTI, recurrent urinary tract infections; VET, vaginal estrogen therapy. Bars represent mean ± SEM. *p<0.05.